Ads
related to: sars-cov-2 virus
Search results
COVID-19 virus disrupts protein production: Researcher discusses her recent findings
Phys.org· 8 hours agoOne thing we do know: Following infection, it's critical that our cells make new proteins to defend against the virus. Writer Jenni Bozec recently spoke with Yerlici—who is based in the lab ...
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 1 day agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...
Moderna seals vaccine deal with Brazil's Health Ministry By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) has secured a contract with Brazil's Ministry of Health to supply 12.5...
It’s Taken 100 Scientists Two Years to Rename Airborne Viruses After Covid Mistakes
Bloomberg· 7 days agoAirborne viruses will be called “pathogens that transmit through the air” under new terminology the...
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
Morningstar· 6 days agoBenitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary ...
New technology uncovers mechanism affecting generation of new COVID variants
Medical Xpress· 2 days agoUnderstanding the genetic mechanism fueling SARS-CoV-2's ability to generate variants can go a long way in keeping COVID at bay. In a study published in Nature Microbiology, researchers at Baylor ...
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National...
Digital Journal· 2 days agoModerna has generated preclinical and clinical data of its monovalent XBB.1.5 vaccine candidate showing an immune response against XBB sublineages and currently circulating strains of the < ...
Xencor (NASDAQ:XNCR) Price Target Cut to $38.00
ETF DAILY NEWS· 7 days agoXencor (NASDAQ:XNCR – Get Free Report) had its target price lowered by analysts at BTIG Research from $56.00 to $38.00 in a research report issued to clients and investors on Tuesday, MarketBeat.com ...
Xencor (NASDAQ:XNCR) Shares Down 4.5% on Analyst Downgrade
ETF DAILY NEWS· 7 days agoXencor, Inc. (NASDAQ:XNCR – Get Free Report)’s stock price was down 4.5% during trading on Tuesday after BTIG Research lowered their price target on the stock from $56.00 to $38.00. BTIG Research ...
